Wikiwand AI

Billy Evans (businessman)

American entrepreneur From Wikipedia, the free encyclopedia

William Evans (born (1992-01-11)January 11, 1992) is an American businessman who founded and runs Haemanthus, a diagnostics start-up based in Austin, Texas. He became the partner of Elizabeth Holmes, the founder of Theranos, in 2017. Evans is featured in the book Bad Blood: Secrets and Lies in a Silicon Valley Startup, the podcast The Dropout, the television miniseries The Dropout, and is a central figure in the 2026 documentary You Can See Everything, directed by Nathan Fielder and Lance Oppenheim.

Born (1992-01-11) January 11, 1992 (age 34)[1]
OccupationBusinessman
TitleChief executive officer of Haemanthus
Quick facts Born, Education ...
Billy Evans
Born (1992-01-11) January 11, 1992 (age 34)[1]
EducationMassachusetts Institute of Technology (BS)
OccupationBusinessman
TitleChief executive officer of Haemanthus
PartnerElizabeth Holmes
Children2
Close

Early life and education

Evans, who grew up in San Diego, is the eldest of three children born to Susan and William L. Evans.[2][3][4] His grandparents, Anne and William D. Evans, opened a hotel on Mission Bay in 1953, which later became Evans Hotels, a family-owned company that operates three properties in Southern California.[5][2][6] One of the hotels is in La Jolla, and two are located in Mission Bay.[7] In an October 2026 statement, the company said that Evans was neither an employee nor a shareholder.[5] Several members of Evans's family, including his mother, uncle, and maternal grandmother, are devout members of the Church of Jesus Christ of Latter-day Saints.[3]

Evans attended the Francis Parker School in San Diego.[2] He then attended the Massachusetts Institute of Technology from 2010 to 2015.[7] Evans played on the men's volleyball team, the MIT Engineers, and graduated in 2015 with a bachelor's degree in economics.[7][5][8] Evans studied abroad at Fudan University in Shanghai in 2013 and 2014.[3][7]

Career

Medical startup and Luminar Technologies

After college, Evans reportedly tried to launch a medical concierge start-up, which did not succeed.[2] Forbes reported that earlier versions of Evans's LinkedIn profile listed him as a strategy and leadership program analyst at LinkedIn until February 2017.[8] He then worked as a special projects manager at the lidar company Luminar Technologies from 2017 to January 2019.[8][6] His LinkedIn profile was later edited to remove every position except Haemanthus.[8]

Haemanthus

Evans has listed himself as the chief executive of Haemanthus since 2022.[5] The company was incorporated in Delaware by late 2023 and is based in Austin.[9] The company shares its name with the flower haemanthus, which is Greek for "blood flower".[7][9][10] The company has not released products.[9][2][8]

Haemanthus is developing a countertop device that uses lasers to analyze blood, urine, and saliva at the molecular level.[7] Rather than shrinking conventional laboratory methods as Theranos attempted, the device is based on Raman spectroscopy.[2][8][9] According to company materials, it would identify biomarkers such as glucose and hormones within seconds and use deep learning models to detect cancer and infections.[9] A patent for the company's Raman spectroscopy system was granted on January 21, 2025.[2][10] The company plans to begin by testing pets before moving to humans. Its long-term goal is a stamp-sized wearable device, which it told investors would take three years and $70 million to develop.[9] The New York Times noted that a photo of the prototype shown to investors resembled the Theranos testing machine.[9]

The company's investor materials stated that its product faced no regulatory oversight and that the United States Department of Agriculture had confirmed this in writing. A USDA spokesperson told the Times that the agency does regulate veterinary diagnostics. Evans provided a partially redacted USDA document stating that the product did not appear to fall within the jurisdiction of the agency's Center for Veterinary Biologics.[9]

Haemanthus first sought $3.5 million from friends and family. In the spring of 2025, it began seeking an additional $15 million from investors in Austin and the San Francisco Bay Area, and its materials described a goal of eventually raising more than $50 million.[9] The venture capitalist Jim Breyer said that his firm declined to invest for many of the same reasons it had passed on Theranos.[9] As of 2025, about a dozen people worked for the company, and much of its leadership had previously worked with Evans at Luminar.[10][9] By 2026, the company reported funding of up to $20 million.[2]

Elizabeth Holmes is not named in the Haemanthus incorporation documents, and the company's investor presentation did not mention Evans's relationship with her.[2][9] In 2025, NPR reported that Holmes had been advising Evans on the company from prison, though a source familiar with the company said that she did not plan to take a formal role.[10][11] A person familiar with the business told The Wall Street Journal that she is not involved.[2] In a 2025 thread on X, the company acknowledged Evans's relationship with Holmes and said that it was "not Theranos 2.0".[10][2] In You Can See Everything, however, Evans accepts that description, and he and Holmes are shown on fundraising calls and discussing product development.[2] A chemistry professor at the University of California, Irvine who consults for the company told Wired that its engineering ideas were credible and that it was not a repeat of Theranos.[2]

Personal life

Evans met Holmes in 2017 at a Fleet Week event in San Francisco, while she was under federal investigation.[5][6][12] The couple became engaged in August 2018, at a Taylor Swift concert during the singer's Reputation Stadium Tour.[7][5][13] In 2019, they spent six months traveling the United States in an RV.[5] The same year, Business Insider reported they had a private wedding ceremony.[14] People reported they were married as of 2022.[15] During Holmes' federal trial, United States v. Elizabeth A. Holmes, et al., Evans' father Bill attended the court proceedings in a disguise and informed people his name was "Hanson" and that he was a car mechanic.[6] Evans wrote two memos on behalf of Holmes at the sentencing portion of her federal trial in 2022.[7][16] In 2025, Holmes told People that the couple might marry someday.[5][7]

Evans and Holmes have two children, William (born 2021) and Invicta (born 2023).[7][5][17] Holmes has been serving her sentence at Federal Prison Camp, Bryan since May 2023, and Evans lives in Austin with their children.[5] Holmes gave him power of attorney when she began her sentence.[8] She is scheduled to move to a halfway house near Austin in August 2027.[5][7]

In media

Bad Blood: Secrets and Lies in a Silicon Valley Startup, by author and journalist John Carreyrou, included discussion of the early relationship between Evans and Holmes, and their decision to start a family during her federal trial United States v. Elizabeth A. Holmes, et al.[18]

Evans featured in coverage of the trial of Elizabeth Holmes, in the podcast The Dropout by journalist Rebecca Jarvis.[19]

In the American biographical drama television miniseries, The Dropout, created by Elizabeth Meriwether, Evans was portrayed by actor Garrett Coffey.[20][21]

The film, You Can See Everything, began after Holmes contacted A24, which later brought in Nathan Fielder and Lance Oppenheim.[22] Evans and Holmes gave the filmmakers access to their lives during the film's three-year production.[5][17][23] Fielder lived in the couple's home for about a month before Holmes began her prison sentence in May 2023.[5][24] The film was released in theaters in October 2026.[5][17] The Austin, Texas home featured in the film was valued at US$2.5 million.[23]

The film shows Holmes undergoing a full-body scan used to create an AI-generated avatar of her, which Evans controls.[25] He says that his power of attorney allows him to make decisions about her voice and likeness.[25] The film also shows Evans managing Holmes's X account.[6] He says that he often posts without her knowledge or approval, though he says that she writes about 80 percent of the posts.[26] Late in the film, during a meeting with A24 executives and Fielder, it is revealed that Evans demanded a share of the backend profits in exchange for unrestricted access to Elizabeth.[25] Because this meeting occurred after filming began but before contracts were signed, the scene is reenacted with actor Christopher Abbott playing Evans.[25] The film later reports that he dropped the demand.[25][26] On the All-In podcast, Evans said that the film's purpose was "to have people see who she is".[17]

Further reading

  • Lin, Bilin (October 25, 2026), "Billy Evans's 'Theranos 2.0' startup has patents, investors, and a missing CTO—but no product", Fortune
  • Vivinetto, Gina (October 16, 2026), "Who Is Billy Evans? Elizabeth Holmes' Partner Seen in 'You Can See Everything' Documentary", Today
  • McCune, Melody (October 16, 2026), "Who Is Billy Evans?", Men's Journal

References

Related Articles

Timelines

Top Qs

Fact Checks